We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

Pharmaceutical Intermediates MarketThe global pharmaceutical intermediates market is set for significant expansion, with revenue expected to grow from USD 36,620.2 million in 2025 to USD 57,031.9 ...

Inc. (Stock code: 300725.SZSE) has announced the official launch of its commercial GMP Workshop 503 (W503) at PharmaBlock Zhejiang. The new workshop significantly enhances production capacity and ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

Biogen has entered a collaboration with Stoke Therapeutics to develop and commercialise zorevunersen to treat Dravet syndrome ...

MSK plans to speed up early-stage drug development by using AWS Drug Discovery Workbench to screen potential candidates.

The Stability Program is being conducted in collaboration with HYTN's GMP-licensed laboratory partner. Upon successful ...

Market OverviewThe Global Contract Research Organization Market was valued at USD 69.25 Billion in 2022 and is projected to ...

Biopharmaceutical CMO Market Rapid outsourcing trends and robust investments in advanced manufacturing drive the biopharmaceutical CMO mark ...

However, the shift of strategic direction to wellness has raised uncertainty over Kirin’s long-term growth prospects, where execution plays a key role in integrating the acquired subsidiary and ...

Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...